ArticleCurrent pharmaceutical design2026
Mendelian Randomization Study on Serum Metabolites and Diabetic Nephropathy Risk: Identifying Potential Biomarkers for Early Intervention.
Siyuan Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.